ClinicalThought

Share

Program Content

Activities

  • BCMA-Targeted Therapies for Multiple Myeloma
    Current and Future Roles of BCMA-Targeted Therapies for Multiple Myeloma
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: February 02, 2022

    Expires: February 01, 2023

  • BCMA-Targeted Bispecific Antibodies in R/R MM
    BCMA-Targeted Bispecific Antibodies: A New Approach for Relapsed/Refractory Multiple Myeloma
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: April 14, 2022

    Expires: April 13, 2023

Provided by

ProCE Banner

Supporters

Pfizer, Inc.